Aussen-innen-kur bonn-en.indd

Conducted during the hair clinic sessions at the practice of adjunct professor GeneralHereditary hair loss also remains an unsolved problem for women. At the onset of menopause, women will start that fatal development men may complain about as early as at the beginning of puberty. In addition, many women are at risk as far as their supply of important trace elements is concerned. This supply defi cit can represent an additional risk for already weakened hair roots. Therefore, a dermatological test should examine the effectiveness of a combi- nation treatment, i.e. consisting of an antiandrogen scalp serum and active hair In an open observation, 20 women suff ering from androgenetic and diff use hair loss were selected. Both women in the initial and medium stages of hair thin- e ingestion or administration of other remedies was not permitted before or during the test. Th by means of a hair root analysis (trichogram). Th widespread diagnostic technique to assess the growth condition of hair roots. Due to the natural regeneration, a small part equivalent to about 15% of the hair roots will be in the resting phase (telogen), which will not lead to hair thinning On the other hand, telogen shares of more than 15% are an indicator that the hair growth activity is disturbed. With such increased telogen shares, hair thin- ning must be expected in the medium or long term. Since the trichogram test is limited to a small area, the diagnosis is supplemented with a self-observation by the test subjects via a questionnaire. Th individuals is especially essential, since the suff ering due to increased hair loss signifi cantly impacts the quality of life. Hair loss was rated in fi ve degrees of Over the course of four months, the test subjects massaged a daily portion of the Caff eine Serum thoroughly into the aff ected scalp areas every day and ingested one Plantur 39 Active Hair Capsule in the morning and at night for breakfast Conducted during the hair clinic sessions at the practice of adjunct professor All 20 test subjects completed the test aft er four months. Th rate is an indicator that the test subjects were basically very satisfi ed with the test products used. Drop-out rates of 10 to 20% are very common during such Due to the level of suff ering, the expectations of the test subjects are very high, so that the questionnaire can be rated highly expressive. In the typical androge- Graphic: Reduction in hair loss after 4 months netically aff ected frontal area, the trichogram analysis resulted in an improve- ment of the anagen status in 60% of the test subjects, 25% noted a deterioration during the period under review, and 15% showed an unchanged trichogram status. In addition to the trichogram, it became apparent over the course of the four months that 15% of the test subjects still noticed hair loss, but none of them detected a deterioration. A total of 85% of the test subjects mentioned a reduction in hair loss, 40% of them by two or more levels of severity. At 75%, the willingness of the test subjects to recommend the combination treatment to other aff ected individuals was correspondingly high.
Hereditary hair loss is individually expressed and can show a changing course, depending on hormone activity. As a result, fl uctuations in the trichogram values can be noted in hair loss tests that will qualify during a longer duration of test or therapy. In addition, it is known that a preliminary change of hair can occur during an activation of hair growth, since the old hairs are replaced by new hairs. is shedding eff ect usually occurs during the initial treatment and can last for several weeks before it normalizes. A typical example is the course observed in one test subject. Aft er an initial anagen rate of 81%, a reduction to 77% occurred aft er two months and improved to an anagen of 91% over the further course of erefore, it is important to inform the patients at the start of treatment and encourage them to systematically continue the the- rapy over several months despite this possibility. Apart from the trichogram, the self-assessment is also an important instrument.
Graphic: Recommendation to others after 4 months Conducted during the hair clinic sessions at the practice of adjunct professor SummaryIf we summarize the results of the observation, we must note that a distinct improvement of hair root activity occurs during the ingestion of Plantur 39 Active Hair Capsules and the simultaneous application of the Caff eine Serum, which can be recognized from the trichogram value and the self-assessment of Based on the results, it can be concluded that the applied combination treat- ment of Plantur 39 Active Hair Capsules and Caff eine Serum led to a reduction in hair loss in the fronto-parietal area of the head aft er four months of therapy in patients with androgenetic alopecia without detectable hormonal causes or with alopecia diff usa without an atiologically discernible cause. According to the available results and general dermatological experience, a shorter applica- e regeneration of the hair roots is a slow process. In the case of disorders or exhaustion, it can only show the desired success based on a systematic daily treatment over a longer period of time of four months or more.
For further information, please visit
Expert terminology marked in green is explained in the glossary.


February, 2004 Successful Aging Namenda Now Available to Treat Alzheimer’s Disease Namenda (Na-MEN-da) was approved by the FDA on October 17, 2001. It is now justbeginning to be available in local pharmacies. The Memory Clinic in Bennington hasbeen receiving many inquiries regarding Namenda. Here are some of the mostcommonly asked questions. What is Namenda? Namenda is the first medi

asthma action plan / medication authorization form

Asthma Action Plan/Medication Authorization Form For all children with asthma Mecklenburg County Health Dept. Student Name ______________________________ CMS Student ID# ____________________________________ School/Year ______________________________ Grade/Teacher ______________________________________ Parent/Guardian ______________________ Contact Number (H)

Copyright © 2010-2014 Medical Articles